RUGGIERO, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 606
EU - Europa 518
AS - Asia 406
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1.542
Nazione #
US - Stati Uniti d'America 599
SG - Singapore 160
CN - Cina 118
RU - Federazione Russa 93
FR - Francia 87
GB - Regno Unito 74
SE - Svezia 70
IE - Irlanda 67
VN - Vietnam 60
IT - Italia 52
DE - Germania 44
ID - Indonesia 34
KR - Corea 19
FI - Finlandia 15
TG - Togo 8
CA - Canada 6
IN - India 6
NL - Olanda 4
BE - Belgio 3
HK - Hong Kong 3
JP - Giappone 3
LV - Lettonia 2
PK - Pakistan 2
UA - Ucraina 2
BR - Brasile 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
TN - Tunisia 1
TR - Turchia 1
Totale 1.542
Città #
Chandler 213
Singapore 127
Southend 68
Dublin 65
Dong Ket 36
Jakarta 34
Lawrence 32
Princeton 32
Sindelfingen 30
Beijing 27
Ashburn 20
Jacksonville 20
Seoul 19
Seattle 16
Verona 15
Wilmington 13
New York 12
Woodbridge 12
Ann Arbor 11
Lomé 8
Santa Clara 8
Lappeenranta 7
Norwalk 7
Redmond 7
Bangalore 6
Dallas 5
Rome 5
Boardman 4
Dongguan 4
Guangzhou 4
Helsinki 4
Moscow 4
Shenyang 4
Toronto 4
Walsall 4
Amsterdam 3
Hong Kong 3
Houston 3
Kent 3
Los Angeles 3
Nanjing 3
San Mateo 3
Tianjin 3
Tokyo 3
Tombolo 3
Brussels 2
Cambridge 2
Elora 2
Haikou 2
Hebei 2
Jinan 2
Malcesine 2
Munich 2
Nanchang 2
Sant'Ambrogio di Valpolicella 2
Taizhou 2
Udine 2
Vercelli 2
Alexandria 1
Almere Stad 1
Antwerp 1
Arnsberg 1
Athens 1
Atlanta 1
Bari 1
Boston 1
Buffalo 1
Böblingen 1
Casoria 1
Changsha 1
Chions 1
Dalian 1
Esslingen am Neckar 1
Fairfield 1
Frankfurt am Main 1
Fuzhou 1
Hangzhou 1
Islington 1
Kronberg 1
Langfang 1
Laurel 1
Legnago 1
Lisbon 1
Madrid 1
Newark 1
Ningbo 1
Nuremberg 1
Oristano 1
Riga 1
Roverbella 1
San Francisco 1
Shanghai 1
São Paulo 1
Taiyuan 1
Vigasio 1
Washington 1
Wuxi 1
Yicheng 1
Zhengzhou 1
Šiauliai 1
Totale 985
Nome #
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 119
HLA-C presence increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41 118
Comparative analysis and generation of a robust HIV-1 DNA quantification assay 52
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 49
Blood CXCR3+ CD4 T cells are enriched in inducible replication competent HIV in aviremic antiretroviral therapy-treated individuals 48
Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART 47
Factors associated with persistence of plasma HIV-1 RNA during long-term continuously suppressive firstline antiretroviral therapy 47
Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children 45
Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers 44
OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines 44
Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2 43
BNT162B2 mRNA COVID-19 vaccine in heart and lung transplanted young adults: is an alternative SARS-CoV-2 immune response surveillance needed? 43
During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR/DP/DQ 42
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy 41
Highly specific memory B cells generation after the 2nd dose of BNT162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal IgA 41
The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: 'The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa' by Lemoine et al 40
Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies 40
Higher PIK3C2B gene expression of H1N1+ specific B-cells is associated with lower H1N1 immunogenicity after trivalent influenza vaccination in HIV infected children 39
The immunology of Multisystem Inflammatory Syndrome in children with COVID-19 39
Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring 38
Generation of liposomes to study the effect of Mycobacterium Tuberculosis lipids on HIV-1 cis- and trans-infections 37
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies 36
Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort) 36
Clinical, virological and immunological subphenotypes in a cohort of early treated HIV-infected children 34
Measuring proviral HIV-1 DNA: hurdles and improvements to an assay monitoring integration events utilising human Alu repeat sequences 34
The HCV envelope glycoprotein down-modulates NF-κB signalling and associates with stimulation of the host endoplasmic reticulum stress pathway 33
Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana 32
Measuring the success of HIV-1 cure strategies 32
Increased prevalence of unstable HLA-C variants in HIV-1 rapid-progressor patients 31
Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology 30
Targeted protein degradation tools: overview and future perspectives 29
Advanced cellular models for rare disease study: exploring neural, muscle and skeletal organoids 28
HIV and SARS-CoV-2 co-infection: from population study evidence to in vitro studies 26
A quantitative method for the study of HIV-1 and Mycobacterium tuberculosis co-infection 25
Utility of integrated HIV-1 DNA quantification in cure studies 24
Pseudotyped viruses as a molecular tool to monitor humoral immune responses against SARS-CoV-2 via neutralization assay 23
Size of HIV-1 reservoir is associated with telomere shortening and immunosenescence in early-treated European children with perinatally acquired HIV-1 22
Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity 20
Subjects who developed SARS-CoV-2 specific IgM after vaccination show a longer humoral immunity and a lower frequency of infection 20
Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine 13
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection 12
Immune signature in vaccinated versus non-vaccinated aged people with COVID-19 pneumonia 5
Totale 1.601
Categoria #
all - tutte 8.887
article - articoli 8.153
book - libri 0
conference - conferenze 734
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.774


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 3 3 4 2 4 4 0 5
2020/2021119 8 2 0 3 4 2 0 2 2 0 32 64
2021/2022140 8 13 1 5 1 1 2 12 7 7 41 42
2022/2023600 42 63 55 96 46 130 10 40 82 9 18 9
2023/2024273 13 20 17 37 18 34 29 15 4 29 36 21
2024/2025344 44 52 35 193 20 0 0 0 0 0 0 0
Totale 1.601